IL109701A0 - THe use of dihydrolipoic acid as an opthalmological agent and to suppress intolerance reactions in the area between implants and living body - Google Patents

THe use of dihydrolipoic acid as an opthalmological agent and to suppress intolerance reactions in the area between implants and living body

Info

Publication number
IL109701A0
IL109701A0 IL10970194A IL10970194A IL109701A0 IL 109701 A0 IL109701 A0 IL 109701A0 IL 10970194 A IL10970194 A IL 10970194A IL 10970194 A IL10970194 A IL 10970194A IL 109701 A0 IL109701 A0 IL 109701A0
Authority
IL
Israel
Prior art keywords
opthalmological
implants
suppress
agent
area
Prior art date
Application number
IL10970194A
Other languages
English (en)
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934317173 external-priority patent/DE4317173C2/de
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of IL109701A0 publication Critical patent/IL109701A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10970194A 1993-05-22 1994-05-20 THe use of dihydrolipoic acid as an opthalmological agent and to suppress intolerance reactions in the area between implants and living body IL109701A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934317173 DE4317173C2 (de) 1993-05-22 1993-05-22 Verwendung von Dihydroliponsäure als Ophthalmologicum

Publications (1)

Publication Number Publication Date
IL109701A0 true IL109701A0 (en) 1994-08-26

Family

ID=6488744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10970194A IL109701A0 (en) 1993-05-22 1994-05-20 THe use of dihydrolipoic acid as an opthalmological agent and to suppress intolerance reactions in the area between implants and living body

Country Status (11)

Country Link
US (1) US5691379A (forum.php)
EP (1) EP0697863A1 (forum.php)
JP (1) JPH08511246A (forum.php)
AU (1) AU6566794A (forum.php)
CA (1) CA2162467A1 (forum.php)
DE (1) DE4345199C2 (forum.php)
IL (1) IL109701A0 (forum.php)
PH (1) PH31652A (forum.php)
TW (1) TW265264B (forum.php)
WO (1) WO1994027592A1 (forum.php)
ZA (1) ZA943514B (forum.php)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19726251C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme zur Behandlung von Uveitis
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
WO2000074672A1 (en) * 1999-06-09 2000-12-14 Department Of The Army, U.S. Government Method and compositions for treating and preventing retinal damage
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8697109B2 (en) 2000-08-16 2014-04-15 Encore Health, Llc Caged mercaptan and seleno-mercaptan compounds and methods of using them
US7935332B2 (en) * 2000-08-16 2011-05-03 Encore Health, Llc Presbyopia treatment by lens alteration
US8647612B2 (en) * 2008-03-05 2014-02-11 Encore Health, Llc Dithiol compounds, derivatives, and treatment of presbyopia
US7914815B2 (en) * 2000-08-16 2011-03-29 Encore Health, Llc Method for delivery of pharmaceuticals for treating or preventing presbyopia
US20050112113A1 (en) * 2000-08-16 2005-05-26 Till Jonathan S. Presbyopia treatment by lens alteration
US8147816B2 (en) * 2000-08-16 2012-04-03 Encore Health, Llc Presbyopia treatment by lens alteration
US8795706B2 (en) 2000-08-16 2014-08-05 Encore Health, Llc Methods of treating ocular diseases using derivatives of lipoic acid
US8557868B2 (en) 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
DK1331902T3 (da) * 2000-11-08 2008-12-08 Fxs Ventures Llc Forbedrede ophthalmiske og kontaktlinseoplösninger indeholdende former af vitamin B
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US9492581B2 (en) 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
WO2004091438A2 (en) * 2003-04-15 2004-10-28 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing peptides as representative enhancers
ITLO20060004A1 (it) * 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
US8102027B2 (en) * 2007-08-21 2012-01-24 Broadcom Corporation IC package sacrificial structures for crack propagation confinement
WO2009111635A2 (en) 2008-03-05 2009-09-11 Encore Health, Llc Dithiol compounds, derivatives, and uses therefor
US9044439B2 (en) * 2008-03-05 2015-06-02 Encore Health, Llc Low dose lipoic and pharmaceutical compositions and methods
EP2821405B1 (en) 2009-06-15 2016-04-13 Encore Health, LLC Choline esters for treating presbyopia and cataract
BR112016020181A8 (pt) * 2014-03-03 2021-06-29 Encore Vision Inc composições de ácido lipoico éster colina e métodos de uso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
BE1003834A5 (fr) * 1989-11-09 1992-06-23 Asta Medica Ag Medicaments qui contiennent, comme substance active, des acides carboxyliques contenant du soufre, ainsi que leur utilisation pour lutter contre des retrovirus.
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E

Also Published As

Publication number Publication date
US5691379A (en) 1997-11-25
TW265264B (forum.php) 1995-12-11
CA2162467A1 (en) 1994-12-08
DE4345199A1 (de) 1994-12-01
AU6566794A (en) 1994-12-20
EP0697863A1 (de) 1996-02-28
PH31652A (en) 1999-01-12
ZA943514B (en) 1995-02-02
WO1994027592A1 (de) 1994-12-08
DE4345199C2 (de) 1995-10-12
JPH08511246A (ja) 1996-11-26

Similar Documents

Publication Publication Date Title
IL109701A0 (en) THe use of dihydrolipoic acid as an opthalmological agent and to suppress intolerance reactions in the area between implants and living body
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
PL330273A1 (en) Cosmetic and/or dermatologic composition in the form of ascorbic acid based powder
HUP0103236A2 (hu) Bőr- és szövetápoló és/vagy kezelő készítmény
PL332547A1 (en) Skin care compositions containing an acid and retinoide
CA2135999A1 (en) Biotherapeutic Cell-Coated Microspheres
GB0015235D0 (en) Compositions for the treatment of skin and anorectal conditions
GB2307295B (en) Transcutaneous measurement of substance in body tissues or fluid
PL341058A1 (en) Compositions useful in reducing weight of patient's body
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
PL309386A1 (en) Ortho-amino-substituted benzoyl guanidines, method of obtaining them their application as therapeutric or diagnostic agents and therapeutic agent containing them
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
AU3200393A (en) Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same
GB9704807D0 (en) Gel for application to the human or animal body
AU7476494A (en) Use of n-methyl-aspartic acid for enhancing growth and altering body composition
FR2685867B1 (fr) Compositions contre la desquamation de l'epiderme et du cuir chevelu.
AU7043987A (en) Fungi and algae detection in animal and human tissues and body fluids
GB2321644B (en) Cosmetic composition for the treatment of the hair and/or the body
IL109981A0 (en) Body care compositions containing colloidal silica and methods for the preparation and use thereof
GB9307948D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
GB9412606D0 (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
EP0456204A3 (en) Use of benzocycloheptathiophenecarboxylic acid derivatives in the treatment of eosinophile accumulation/activation and connected diseases
AU6966494A (en) Zinc monoglycerolate complex for anti-rejection treatment of the human or animal body
TW296620U (en) Device to change the posture of human body
AU1178195A (en) Therapy and diagnosis of conditions related to telomere length and/or telomerase activity